Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

PHASE3CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

November 21, 2017

Study Completion Date

November 21, 2017

Conditions

Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Interventions

DEVICE

YYD701-2

HA Filler

DEVICE

Restylane Perlane Lidocaine

HA Filler

Trial Locations (2)

Chung-Ang Univ. Medical Center, Seoul

Konkuk University Medical Center, Seoul

All Listed Sponsors

lead

Yooyoung Pharmaceutical Co., Ltd.

INDUSTRY

NCT03170050 - Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds | Biotech Hunter | Biotech Hunter